Optimized anti-CD30 antibodies

Details for Australian Patent Application No. 2006302254 (hide)

Owner Xencor, Inc

Inventors Desjarlais, John R.; Lazar, Gregory Alan; Karki, Sher Bahadur; Chu, Seung Y.; Carmichael, David F.; Chen, Bao-lu; Hammond, Philip W.

Agent Davies Collison Cave

Pub. Number AU-B-2006302254

PCT Pub. Number WO2007/044616

Priority 60/750,697 15.12.05 US; 60/737,998 18.11.05 US; 60/724,624 06.10.05 US; 60/776,598 24.02.06 US; 60/745,536 25.04.06 US

Filing date 6 October 2006

Wipo publication date 19 April 2007

Acceptance publication date 26 May 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/044616 Priority application(s): WO2007/044616

26 May 2011 Application Accepted

  Published as AU-B-2006302254

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006302256-Systems and methods for response monitoring

2006302251-Apparatus system and method for realtime migration of data related to authentication